戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 dy of adults 18 years or older who underwent any of 10 common surgical procedures between 2010 and 20
2                  We failed to detect Bsal in any of 11,189 samples from 594 sites in 223 counties wit
3 ; cohort B (142 patients) had alterations in any of 12 other prespecified genes, prospectively and ce
4 s caused by inherited pathogenic variants in any of 22 genes.
5                                  Carriage of any of 3 coding NUDT15 variants was associated with an i
6 on elderly Medicare beneficiaries undergoing any of 4 elective inpatient surgical procedures between
7              Rare pathogenic DNA variants in any of 49 genes can pre-dispose to 4 important causes of
8            Observed DNA sequence variants in any of 49 genes with known association to cardiovascular
9 nd (v) concomitant presence of antibodies to any of 6 nongenital HPV types (chi2 = 40.1; P < .0001).
10            During follow-up, jaw injury from any of 9 types of potentially traumatic events was deter
11 hen triggered by ingestion of fava beans, by any of a number of drugs (for example, primaquine, rasbu
12 ted age, was death or disability, defined as any of cognitive deficit, cerebral palsy, or severe visu
13           We sought to identify the role, if any, of COX1-derived prostacyclin in antithrombotic prot
14          Induced loss-of-function alleles of any of five Six-rowed spike (VRS) genes (VRS1-5) cause c
15 rowth factor, and others) were found between any of groups.
16 ds ratio [aOR], 1.27 [95% CI, 1.18-1.36]) or any of its consequences, including high financial distre
17 e structural arrangement of this receptor or any of its family members.
18 the binding of the std20S or i20S subtype to any of its PA28 activator triggers allosteric changes th
19  tree, and can compare an extant genome with any of its reconstructed ancestors to understand how the
20 e oxide (GO) phases is vitally important for any of its widespread intended applications: highly orde
21 garding patients aged >=18 years admitted to any of Maryland's 50 acute-care hospitals were evaluated
22                We also examined the role, if any, of mitochondrial turnover in this process.
23                              Availability of any of one hospital-based resource (palliative care cons
24 observed between plant and mammalian mAbs in any of our in vitro or in vivo evaluations.
25 ndicate that RNP formation was unaffected by any of our modifications.
26 ly, we could not detect yuzunone by GC-MS in any of our samples.
27  structure of the pain matrix and the DMN in any of our two independent cohorts.
28 udies are required to explore the effect, if any, of post-TCP conjunctival changes on future bleb mor
29 pheric side had not significant influence on any of quantitative estimates.
30 lta [psi-] cells, but not if the cells carry any of several [PSI+] variants.
31 for 2 oriented gratings that could appear in any of several locations.
32 engineered mouse models with inactivation of any of several SWI/SNF subunits.
33  and managed honey bees, and 3) determine if any of six commonly occurring honey bee-associated virus
34 ition algorithms to identify if a person had any of six NCDs (cancer, cardiovascular disease [CVD], d
35 reast epithelial cell line stably expressing any of six of the most prominent proliferative oncogenes
36 ny of the perfusion property measurements in any of the 10 ROIs between the methods.
37 and the lowest MIC(90) value (4 mg/liter) of any of the 12 agents tested.
38         Contrarily, ADRVDs were not found in any of the 12 eyes without central VF loss.
39  differences in the frequency or severity of any of the 12 individual symptoms assessed.
40 iables were used to identify the presence of any of the 15 possible comorbidity pairings of these six
41 l structural rearrangements were observed on any of the 19 chromosomes among the five species.
42 issue diagnosis, malignancy was not found in any of the 196 lesions (0%) (95% confidence interval: 0.
43 itrary molecular features can be selected in any of the 1D/2D/3D windows as sets of residues and thes
44 ically significant differences were noted in any of the 24 prespecified secondary outcomes.
45 ty against meningococci displaying fHbp from any of the 3 different variant groups.
46     The absence of a significant tropism for any of the 3 genetically distinct bat ACE2 proteins we e
47 , and 12 patients showed positive results by any of the 3 methods (mean Ct value, 32.16 +/- 1.94), th
48  compared with delayed iron had no effect in any of the 3 study groups on the primary study outcomes
49  All adults (aged >=15 years) who resided in any of the 30 districts of Rwanda for 10 or more years w
50                           It is not found in any of the 30 other carnivorans-both Felidae and Canidae
51 2 tests were not significantly different for any of the 4 criteria and ranged from 0.88 to 0.93 and f
52 es, there were no significant differences in any of the 4 functional outcomes between the 0.40 mg/kg
53 ceived a first-time ICD or CRT-D device from any of the 4 major manufacturers (January 1, 2016-Decemb
54                          We analysed whether any of the 49 polymorphisms in CYP2C9 and VKORC1 previou
55 r children, if the child received vaccine in any of the 5 campaigns delivering bivalent OPV (serotype
56               Myopia was not associated with any of the 5 DR outcomes in the unadjusted models and on
57 tive numeracy, and younger age, but not with any of the 5 factors.
58 dergone bariatric surgery in 1982 to 2012 in any of the 5 Nordic countries, with follow-up through 20
59 elopability liabilities, and did not bind to any of the 5,300 human membrane-associated proteins test
60 f injury deaths following hospitalization in any of the 57 trauma centers in a Canadian trauma system
61     There were no significant differences in any of the 6 prespecified comparative secondary outcomes
62 pecific IgE level of 0.35 kU/L or greater to any of the 8 common food allergens determined by using I
63 obank and 9063 individuals who did not carry any of the 93 copy number variants reported to be pathog
64 lthy plant-based diet index was unrelated to any of the abdominal or liver fat parameters.
65 ction did not show significant prediction of any of the above global cognition measures.
66 ange in normalised substrate utilisation for any of the activities (p > 0.05).
67 ind that <10% of protected areas are home to any of the alien animals, but there is at least one esta
68                       No correlation between any of the analyzed molecular marker (mutations or ampli
69 did not modify significantly the response to any of the AREDS2 supplements.
70                  Cadmium was not rejected in any of the assays, and ingesting cadmium did not alter s
71                   By accommodating data from any of the available rNMP sequencing techniques, Ribose-
72 r" or a heterogeneous off-register manner to any of the available sites on a multivalent partner.
73     No protein extract was effective against any of the bacteria strains tested at antimicrobial assa
74 s, policy assessments have considered few if any of the benefits to children.
75 s where there is no uniquely mapping read to any of the candidate target genes.
76 tionship between the composite end point and any of the cardiac MRI parameters, including LVH (P = .1
77 s no statistically significant difference in any of the cardiometabolic markers between groups.
78  no statistically significant differences in any of the CC parameters within the drusen resolved regi
79 tiproliferative effects of PTK2 depletion in any of the cell lines tested.
80 re not informed of assignment or outcomes at any of the centres.
81 on groups on any measure of anthropometry or any of the child development outcomes in the full sample
82  unaffected by deficiencies in signaling for any of the classical defense hormones.
83 ) and FSL-1, we found Mtb LAM did not induce any of the classical PMN priming phenotypes, including e
84 ude larger than projected expenditures under any of the climate scenarios.
85 iations between the hepatic fat fraction and any of the clinical or laboratory variables.
86 est, oxy-haemoglobin was not associated with any of the clinical variables studied.
87 not incorporated as a contributing factor in any of the commonly used severity of illness scores.
88  the redox state of Q(A) within PSII without any of the complications of traditional F (v) /F (m) mea
89 cant differences in subjective evaluation in any of the conditions whereas many statistically signifi
90 ethnic group did not have the lowest U5MR in any of the countries studied.
91 is narrower than any previously reported for any of the CsPbBr(3) NCs, and for zeolite Y and the vari
92 al stasis does increase biomarker levels for any of the cytokines examined in our study.
93      Based on our assumptions, a trial using any of the designs considered would require tens of thou
94 g growth times, which makes it unlikely that any of the diamonds in ureilites formed in bodies as lar
95                   GI was not associated with any of the dicarbonyls or AGEs.
96 , respectively), which did not correspond to any of the dyes reported earlier.
97 al replication was detectable in the nose of any of the eight animals in the 100-mug dose group by da
98 ant, the gH-null mutant was unable to infect any of the epithelial, endothelial, or fibroblast cell t
99               There is no cross-talk between any of the ESX systems, and how each EspG recognizes its
100 ic disc measures predicted VF progression in any of the explored models.
101 rs, there were no clear associations between any of the exposures and either of the outcomes.
102             However, no DET was observed for any of the films as indicated by the absence of expected
103 ment, we found that null homozygotes lacking any of the five different ribosomal proteins (RPs) can p
104 pression of wild type (WT) UBQLN2 but not by any of the five different UBQLN2 ALS/FTD mutants tested.
105  harvested was found between the control and any of the five treatments.
106 s any further glaucoma procedure post-SLT or any of the following at 2 consecutive visits: IOP >21 mm
107      Patients aged 65 or older who underwent any of the following general elective surgeries: abdomin
108  a composite of all patients presenting with any of the following outcomes: radiological objective re
109 m 2016 to 2019 to locate ED patients who had any of the following: D-dimer, CTPA, scintillation venti
110  number of hypotensive events, as defined by any of the following: decrease in systolic blood pressur
111 tive depression status was defined as having any of the following: elevated depressive symptoms, anti
112 urvival for patients with stage I disease in any of the four countries.
113 ring hotspot mutations in Galpha subunits of any of the four families of heterotrimeric G-proteins ar
114 gene defects, it is unclear how mutations in any of the four known ICF genes cause a primary immunode
115                           Thus, potentially, any of the four PDE4 subtypes may be targeted individual
116 loroclozapine did not differ from vehicle in any of the four subjects.
117 gitudinal records on receipt of treatment in any of the four treatment rounds of the study.
118                                 Mutations in any of the genes encoding the four subunits of succinate
119 idazoles (4-MEI and THI) were not present in any of the GlcN-amino acid caramels.
120 ntagonists had little effect on responses to any of the glucocorticoids tested.
121 ian overall survival has not been reached in any of the groups.
122 junction integrity was not different between any of the groups.
123   There were no significant complications in any of the groups.
124  of acute or chronic stress were observed in any of the groups.
125 tween the S atom of SAM and Tyr68 or between any of the H atoms of the transferring methyl group and
126 ed on a distance-based proxy measurement and any of the hazard-specific metrics.
127 primary safety end point of lead failure for any of the high energy leads studied.
128 immunohistochemical stains did not downgrade any of the histomorphologically high-grade lesions.
129 The CAD system achieved higher accuracy than any of the individual 53 nonexpert endoscopists, with co
130 cation was not associated with compliance in any of the infection prevention and control domains.
131                There were no main effects of any of the intervention groups on any measure of anthrop
132 ssion of CM-related methylation profiles for any of the investigated epigenetic sites.
133 onalized neutral surfaces are faster than on any of the ionic surfaces but still slower than the bulk
134 n chains can be presented for degradation by any of the known receptors, whereas those targeted to th
135  treated and untreated orbit was observed in any of the main outcome measures at 6 months.
136 ts on endogenous circadian timekeeping or on any of the major output functions of the small ventral l
137 o differences between the cytokine levels of any of the measured biomarkers between the achalasia and
138     There were no other associations between any of the measured parameters, distress or mindfulness.
139 ngation, the need to prematurely discontinue any of the medications due to QT prolongation, and arrhy
140                                       (4) Do any of the metabolites possess activity, either on- or o
141 ns of protein intake in early childhood with any of the mid-childhood outcomes.
142 e of the amidic substituent was observed for any of the N-(hydroxybenzyl)benzamide derivatives studie
143 nds, PEGs, and nonhydrophobic peptides using any of the nebulizers tested.
144 bined 30-day HF readmissions or mortality in any of the neighborhood quartiles.
145 that there is no detectable homology between any of the normal A chromosomes and the B chromosome.
146                                     Also, do any of the novel biased agonists live up to their initia
147 task-specific responses are not clustered in any of the nuclei, suggesting that single-units may be t
148 verse events reported at a frequency >=5% in any of the olanzapine plus samidorphan groups and occurr
149 ts evidenced significant microbial cfDNA for any of the organisms examined.
150 142 patients with at least one alteration in any of the other 12 prespecified genes.
151                     It was not clear whether any of the other 29 genes in the 1.3-Mb M-locus are also
152 lative risk, 1.00 [95% CI, 0.86-1.16]) or in any of the other 6 clinical maternal and neonatal second
153 few direct synapses onto VTA MC3R neurons or any of the other major neuronal subtypes in the VTA, des
154                   There was no difference in any of the other maternal and offspring complications be
155 id not have genetically predicted effects on any of the other phenotypes after correcting for multipl
156 PAN was more accurate and more specific than any of the other pipelines and was almost as fast as any
157 ce of a difference between the protocols for any of the other secondary outcomes.
158 etween HIV-exposed and unexposed children on any of the outcomes were minimal and not significant.
159  1.56, p<0.01) but HT did not associate with any of the outcomes.
160 exclusive or more remarkably, not present in any of the parent.
161 P650 portions of virus-carried transgenes in any of the passaged viruses, demonstrating long-term gen
162 ere found in the virus-carried transgenes in any of the passaged viruses.
163 m was not clinically suspected antemortem in any of the patients.
164 sease progression on SW-FAF was observed for any of the patients.
165 um depressive symptoms (7% of women) or with any of the perceived stress trajectories.
166  no statistically significant differences in any of the perfusion property measurements in any of the
167                             No difference in any of the perioperative complications was seen between
168 ilarities to but also clear differences from any of the polymorphic 2N4R folds.
169  No significant differences were observed in any of the pre- and postsynaptic variables measured.
170 icant differences between the two groups for any of the prespecified safety endpoints.
171 ant between-group differences were found for any of the prespecified secondary outcomes, including ch
172 he other symptomatic groups and controls, or any of the presymptomatic mutation carriers and controls
173 d with the FDA from 2010-2019 was lower than any of the previous three decades.
174 rences were found between the two groups for any of the primary or secondary outcomes.
175 ically significant differences were seen for any of the primary outcomes for the child (death or any
176 the intervention had no measurable effect on any of the primary outcomes.
177         No severe adverse events occurred in any of the procedures.
178 teractome which showed the drugs that target any of the proteins in the interactome.
179 dings, MHC heterozygosity was not related to any of the psychological life history-relevant variables
180 peutic strategy to affect tumours expressing any of the range of KRAS mutations.
181  radicals (DMPO) were tested to determine if any of the reactive species were involved in the degrada
182 ns-produce sustained pain, without affecting any of the reflexive defensive reactions that we tested.
183 th respect to age, parity, and gravidity for any of the regions.
184              No association was observed for any of the remaining polyphenols with total differentiat
185  of the original report, we do not replicate any of the reported associations.
186  and epidemiologic evidence does not support any of the reviewed vaccine safety concerns.
187                                   When using any of the risk factors age, notified or oral sex as tes
188                                   When using any of the risk factors age, notified, or oral sex as te
189 o detect seropositive autoantibodies against any of the salivary-enriched proteins in the SS and ICIS
190  biomass, was not significantly predicted by any of the same leaf constituents in the two plant speci
191 ignificant differences between the groups on any of the secondary efficacy measures.
192 core, 0.02 [CI, -0.27 to 0.31]; P = 0.80) or any of the secondary end points.
193     There were no significant differences in any of the secondary outcomes.
194 nificant differences between study groups in any of the secondary participant end points.
195 re was no effect of the CAPS intervention on any of the secondary trial outcomes.
196 rocyte would respond to neuronal activity in any of the sensory modalities, perhaps integrating acros
197              There were no marked changes in any of the serum enzymes activities.
198 arameter and cpRNFL thickness measurement at any of the severities (P > 0.05).
199 KcsA, but that even a single K(+) binding at any of the SF sites, except S4, can rescue the conductiv
200 urther confirm the absence of Dirac cones in any of the silicene phases due to the strong Ag-Si hybri
201 pecific two amino acid deletion, rather than any of the single or more amino acid deletions, in the K
202 arly Progonomys, which cannot be assigned to any of the species of the genus hitherto described.
203 disease-peripheral T-cell lymphoma-let alone any of the specific subtypes, except advances made for p
204 none of the cases showed neuritic plaques on any of the stains used.
205  largest class is not reliably responsive to any of the stimuli and becomes progressively larger in h
206 Neurologic prognostication was not a part of any of the structured pathways.
207 as it did not show NO scavenging activity in any of the studied environments.
208                 There were no serious AEs in any of the study arms.
209 her at screening, and no known resistance to any of the study drugs.
210 ce for significant effects of probiotics for any of the study's endpoints on those complying with the
211    No significant side effects were noted by any of the subjects.
212 hile motor cortex, showed no obvious loss in any of the subsets of interneurons after TBI.
213  tolerance was not significantly affected by any of the sweetener treatments.
214  by the percentage of patients who presented any of the symptoms each day, was also higher in cases t
215 t relationship with anxiety-like behavior in any of the targeted brain regions, serotonin transporter
216  patients with loss-of-function mutations in any of the targeted genes compared with patients with no
217       Anti-oxidative synergy was not seen in any of the tested lycopene-anthocyanin mixtures, nor in
218 ed to have no sepsis aetiology identified by any of the tested methods, sequencing identified microbi
219  but imidacloprid resistance was not high in any of the tested strains.
220 g structure of an activated AGPCR to support any of the theories.
221 ection showed no detectable antibodies using any of the three assays 43 days after onset of symptoms.
222  twin introns (stwintrons) are introns where any of the three consensus sequences involved in splicin
223 ing on the polymer's structural arrangement, any of the three contributions prevails for the stronges
224                                              Any of the three drugs can be considered as a potential
225 esults suggest why inactivating mutations in any of the three human genes leads to similar clinical p
226                The mean thrombus score using any of the three scoring systems yielded greater scores
227 r, the G729R E1a substitution did not affect any of the three side-reactions associated solely with G
228          In humans and rodents, mutations in any of the three transporters lead to dysregulation of e
229             The medians were not reached for any of the time-to event end points for either the BR or
230 r cell, and other quality control metrics in any of the tissues within the first 24 h.
231 nts for DIC but are gravely insufficient for any of the TMA disorders that involve disorders of compl
232 o symptoms of phytotoxicity were observed in any of the treated trees.
233 bination therapy will be more effective than any of the treatment strategies used in isolation.
234          IL-6 and IL-10 were not affected by any of the treatments applied while IL-8 and TNF-alpha w
235 hereas the inhibitor STC2 did not respond to any of the treatments.
236 1) is not due to alteration of the levels of any of the ubiquitin ligases known to ubiquitinylate p27
237 ues revealed no significant association with any of the underlying brain pathologies.
238 for hernia repair and no correlation between any of the utilization measures for laparoscopic appende
239   This was accomplished without interrupting any of the viral ORFs, yielding recombinant viruses that
240 laboratory aspects, hence any improvement in any of the workflow steps would be welcomed.
241 lations; 29 of these species do not occur in any of the younger Holocene sites (or in the Bahamas tod
242 es TSH levels, the clinical significance, if any, of the rise in TSH is unclear.
243  similar to the strain dependence of J(c) of any of their underlying component parts, but is amenable
244 -CoV-2 positive cases as possible than using any of them alone.
245 ptomatic throughout their lifetime; however, any of them may develop acute and sometimes very severe
246 died these drugs further to identify whether any of them may potentially be repurposable for schizoph
247 he other pipelines and was almost as fast as any of them.
248 des no justification for ignoring drivers of any of these 3 types when projecting ecological and evol
249                                              Any of these alterations in the gene content could be th
250  molecules into the circulation, but whether any of these anabolic functions provides insight on kidn
251   Early recognition and early treatment with any of these antimicrobial classes remain the most impor
252  ester accumulation following treatment with any of these ART drugs by >37% ( P<0.05).
253                              Furthermore, if any of these aspects involved have abnormalities, e.g.,
254  terminals in the accumbens had no effect on any of these behaviors.
255 ferences in exhausted CD8(+) T cells, nor in any of these CD4(+) T cell subsets between groups.
256 neity were not statistically significant for any of these comparisons.
257 y used in photonics, it has yet to replicate any of these complex naturally occurring structures.
258 s field to evaluate the effect of addressing any of these concerns on the implementation of ISBCS.
259 ld odds (95% CI, 1.31-2.00) for experiencing any of these conditions.
260  examination; or reoperation without meeting any of these criteria.
261 her, there was no direct association between any of these cytokines and eosinophil IL-16 content.
262 ers) had no enhanced interferon responses at any of these days.
263 etically reduce lifetime risk for developing any of these diseases by 20%-50%.
264 sults have not led to regulatory approval of any of these drugs for a HF indication or a recommendati
265                              Inactivation of any of these genes reduces DBL-1/BMP signaling, measured
266                                Knockdowns of any of these genes result in impaired hormone-induced fl
267 oes not demonstrate a consistent benefit for any of these interventions.
268                             Dysregulation of any of these lineages could contribute to complex diseas
269 ion-ion interactions do not adversely affect any of these measurements.
270 here is no electrochemical data available on any of these metabolites.
271 ceed film can hardly prevent the adhesion in any of these models.
272                Some 500 million persons with any of these mutations are mostly asymptomatic throughou
273 e CAD, PCI shows no evidence of an effect on any of these outcomes.
274 a progesterone levels did not correlate with any of these parameters, whereas estradiol levels were p
275 oes not play a major role in the response to any of these pathogens.
276            There was no effect of inhibiting any of these pathways on reward sensitivity, locomotion,
277                        Strains deficient for any of these proteins exhibit variable spreading of hete
278                            Overexpression of any of these proteins, including DGCR8, reversed prematu
279        We find no evidence of involvement of any of these receptors in the recruitment of neutrophils
280                                         When any of these resources are compromised, LLAs exhibit poo
281                                              Any of these sensory cues in isolation is an incomplete
282 as little as a 0.1 trophozoite equivalent of any of these species.
283  strong antibody response than observed with any of these species.
284 hout the need to remove or remount it during any of these steps.
285 low differences between groups were found in any of these structures, suggesting nonvascular etiologi
286 opy), revealing that the rates of binding of any of these substrates decreased with increasing substr
287                        Selective ablation of any of these subtypes in mice did not induce gastropares
288                                              Any of these TFs alone were not sufficient to predict op
289 SMM cohort by showing that patients who have any of these three features have a higher risk of progre
290 defined as the first confirmed occurrence of any of these three individual measures), as was time to
291 and regorafenib or documented intolerance to any of these treatments despite dose modifications, and
292       Thus, we raise the question: Which, if any, of these lncRNAs could also represent RNA-based mac
293             However, it is unknown which, if any, of these NET-affiliated proteins is responsible for
294                                      Finding any of this missing information provides proof of princi
295 at awarded 1 point when the concentration of any of those 4 biomarkers was in the top quartile (score
296                                       Unlike any of those methylation signatures, here we describe a
297        Full occlusion was not achieved after any of those procedures.
298 ic acid groups, glucuronidation can occur at any of those.
299                Loss-of-function mutations to any of three genes results in CCM lesion formation; name
300 standing of the etiology of MS, the role, if any, of viruses in propagating pathogenic immune respons

 
Page Top